Since 1996 WHN is the second oldest medical website on the net, second only to the American Medical Association, servicing over 35,000 physicians and scientists worldwide.
Non-Profit Trusted Source of Non-Commercial Health Information
A new analysis found that substituting generic cardiovascular medications for brand-name medications in the Medicare Part D prescription program could save more than $600 million per year in the U.S., including about $135 million in costs to patients. Researchers suggest that adjusting the prescribing patterns of about 8% of physicians who prescribe more brand-name cardiovascular …
According to a press announcement the U.S. Food and Drug Administration approved the first generic of glucagon for injection USP, 1 mg/vial packaged in an emergency kit, for the treatment of severe hypoglycemia (very low blood sugar), which may occur in patients with diabetes mellitus. The drug is also indicated as a diagnostic aid in …
Mylan’s EpiPen and EpiPen Jr epinephrine autoinjectors are the first generic versions to gain FDA approval, in a move that can help increase access to emergency treatment for allergic reactions; and is part of broader federal mandates to help lower costs of medications that not protected by patents or exclusions. Approval was granted for Teva …